Form D · Other
Mindset Pharma Inc.
Toronto, A6 · CIK 0001859156
Offering snapshot reported Apr 27, 2021 · SEC filing
- Reported sold
- $694K Offering amount: $1.71M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2021 | Initial | $694,347 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-397259
Source: Form D, filed Apr 27, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Araujo | Director |
| James Lanthier | Executive |
| James Passin | Director |
| Richard Patricio | Director |
| Arvin Ramos | Executive |
| Jessica Whitton | Executive |
| Philip Williams | Director |
Issuer details
Industry: Other (See others in industry)
Address:
217 Queen Street West, Suite 401
Toronto, A6, M5V 0R2
Toronto, A6, M5V 0R2